Apollo Endosurgery Incの資本の返還
Apollo Endosurgery Incの資本の返還は何ですか。
Apollo Endosurgery Incの資本の返還は-89.48%です。
資本の返還の定義は何ですか。
株主資本利益率は、株主資本の簿価との関係で事業の収益性の尺度です。これは、会計年度純利益を株主資本合計で除算することによって計算されます。
The return on equity (ROE) ROE is a measure of how well a company uses investments to generate earnings growth. ROE is used for comparing the performance of companies in the same industry. It indicated the management's ability to generate income from the equity available to it. ROEs of 15-20% are generally considered good. ROEs are also a factor in stock valuation, in association with other financial ratios. In general, stock prices are influenced by earnings per share (EPS), so that stock of a company with a 20% ROE will generally cost twice as much as one with a 10% ROE.
NASDAQのセクタHealth Careにおける資本の返還の企業と比べるApollo Endosurgery Inc
Apollo Endosurgery Incは何をしますか。
Apollo Endosurgery, Inc. is a medical technology company focused on less invasive therapies to treat various gastrointestinal conditions, ranging from gastrointestinal defect repairs to the interventional treatment of obesity. Apollo's device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 75 countries today and include the X-Tack™ Endoscopic HeliX Tacking System, the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, and the ORBERA® Intragastric Balloon.
Apollo Endosurgery Incと類似の資本の返還
- Guangdong Tanneryの資本の返還は-89.80%です。
- Kin Mining NLの資本の返還は-89.76%です。
- MultiPlanの資本の返還は-89.59%です。
- Prodigy Venturesの資本の返還は-89.51%です。
- 4D pharma plcの資本の返還は-89.48%です。
- 4D pharma plcの資本の返還は-89.48%です。
- Apollo Endosurgery Incの資本の返還は-89.48%です。
- Teladoc Healthの資本の返還は-89.48%です。
- Padmanabh Industriesの資本の返還は-89.33%です。
- Vy Global Growthの資本の返還は-89.30%です。
- Nickel Rock Resourcesの資本の返還は-89.24%です。
- engage:BDRの資本の返還は-89.19%です。
- IR Resourcesの資本の返還は-89.12%です。